Ligand Pharmaceuticals LGND
NASDAQ LGND
$310.36 -3.74 (-1.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Enterprise Value (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) reported Enterprise Value of $4.94 billion for Q2 2026, up 151.8% from $1.96 billion a year earlier and up 53.4% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Enterprise Value (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ligand Pharmaceuticals' Enterprise Value came in at $2.76 billion, up 116.2% year-over-year; for FY2025, it was $3.01 billion, up 67.8% from FY2024.

  • Enterprise Value has increased for three consecutive years, with a five-year compound annual growth rate of 38.7% (FY2020 to FY2025).
  • By year, Enterprise Value came in at $1.79 billion in FY2024 (+65.3%), $1.08 billion in FY2023 (+17.7%), $920.46 million in FY2022 (-27.8%) and $1.27 billion in FY2021 (+117.3%).
  • The Q2 2026 figure ranks as the highest quarterly Enterprise Value in data going back to Q2 2010.
  • Year over year, Enterprise Value has now increased in each of the last 13 quarters, with growth averaging 82.4% over the last eight quarters.
  • The high point for year-over-year Enterprise Value in five years was Q3 2021 (growth of 598.1%); the low point was Q3 2022 (a decline of 30.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.22 billion (Q1 2026), $3.01 billion (Q4 2025) and $2.82 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Ligand Pharmaceuticals 6.26 Bn 2.72 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.94 Bn
Mar 31, 2026 3.22 Bn
Dec 31, 2025 3.01 Bn
Sep 30, 2025 2.82 Bn
Jun 30, 2025 1.96 Bn
Mar 31, 2025 1.82 Bn
Dec 31, 2024 1.79 Bn
Sep 30, 2024 1.66 Bn
Jun 30, 2024 1.30 Bn
Mar 31, 2024 999.65 Mn
Dec 31, 2023 1.08 Bn
Sep 30, 2023 853.36 Mn
Jun 30, 2023 1.03 Bn
Mar 31, 2023 977.71 Mn
Dec 31, 2022 920.46 Mn
Sep 30, 2022 786.14 Mn
Jun 30, 2022 791.72 Mn
Mar 31, 2022 979.14 Mn
Dec 31, 2021 1.27 Bn
Sep 30, 2021 1.13 Bn
API Access

Ligand Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=LGND&period=max&api_key=YOUR_API_KEY